CUMYL-FUBINACA: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:CUMYL-FUBINACA}} | |||
== | == Overview == | ||
CUMYL-FUBINACA is | '''CUMYL-FUBINACA''' is a synthetic cannabinoid that acts as a potent agonist of the [[cannabinoid receptor]]s. It is part of a class of compounds that are often used in the production of [[designer drugs]]. These substances are frequently found in products marketed as "[[spice (drug)|spice]]" or "synthetic marijuana". | ||
== | == Chemical Structure == | ||
CUMYL-FUBINACA | [[File:CUMYL-FUBINACA_structure.png|thumb|right|Chemical structure of CUMYL-FUBINACA]] | ||
CUMYL-FUBINACA is chemically classified as an indazole-based synthetic cannabinoid. Its full chemical name is ''N''-[[(1-(4-fluorobenzyl)-1''H''-indazole-3-carbonyl]])-''L''-valine ''methyl ester''. The presence of the fluorobenzyl group is a distinguishing feature of this compound. | |||
== | == Pharmacology == | ||
CUMYL-FUBINACA acts as a full agonist at the [[CB1 receptor|CB1]] and [[CB2 receptor|CB2]] cannabinoid receptors, which are part of the [[endocannabinoid system]]. This system is involved in regulating a variety of physiological processes including mood, memory, and appetite. The activation of these receptors by CUMYL-FUBINACA can lead to psychoactive effects similar to those of [[tetrahydrocannabinol]] (THC), the active component of [[cannabis]]. | |||
== | == Effects and Toxicity == | ||
CUMYL-FUBINACA | The effects of CUMYL-FUBINACA can include euphoria, relaxation, altered perception, and in some cases, anxiety or paranoia. However, due to its potency, it can also lead to severe adverse effects such as [[tachycardia]], [[hypertension]], [[nausea]], [[vomiting]], and [[seizures]]. There have been reports of fatalities associated with its use, often due to its unpredictable potency and the lack of quality control in its production. | ||
== | == Legal Status == | ||
CUMYL-FUBINACA is classified as a controlled substance in many countries due to its potential for abuse and lack of accepted medical use. It is often included in legislation targeting synthetic cannabinoids and other [[new psychoactive substances]]. | |||
== Related Pages == | |||
* [[Synthetic cannabinoids]] | * [[Synthetic cannabinoids]] | ||
* [[Cannabinoid receptor]] | * [[Cannabinoid receptor]] | ||
* [[ | * [[Spice (drug)]] | ||
* [[Endocannabinoid system]] | |||
[[Category:Synthetic cannabinoids]] | [[Category:Synthetic cannabinoids]] | ||
[[Category:Designer drugs]] | [[Category:Designer drugs]] | ||
Latest revision as of 06:08, 16 February 2025
Overview[edit]
CUMYL-FUBINACA is a synthetic cannabinoid that acts as a potent agonist of the cannabinoid receptors. It is part of a class of compounds that are often used in the production of designer drugs. These substances are frequently found in products marketed as "spice" or "synthetic marijuana".
Chemical Structure[edit]
CUMYL-FUBINACA is chemically classified as an indazole-based synthetic cannabinoid. Its full chemical name is N-(1-(4-fluorobenzyl)-1''H''-indazole-3-carbonyl)-L-valine methyl ester. The presence of the fluorobenzyl group is a distinguishing feature of this compound.
Pharmacology[edit]
CUMYL-FUBINACA acts as a full agonist at the CB1 and CB2 cannabinoid receptors, which are part of the endocannabinoid system. This system is involved in regulating a variety of physiological processes including mood, memory, and appetite. The activation of these receptors by CUMYL-FUBINACA can lead to psychoactive effects similar to those of tetrahydrocannabinol (THC), the active component of cannabis.
Effects and Toxicity[edit]
The effects of CUMYL-FUBINACA can include euphoria, relaxation, altered perception, and in some cases, anxiety or paranoia. However, due to its potency, it can also lead to severe adverse effects such as tachycardia, hypertension, nausea, vomiting, and seizures. There have been reports of fatalities associated with its use, often due to its unpredictable potency and the lack of quality control in its production.
Legal Status[edit]
CUMYL-FUBINACA is classified as a controlled substance in many countries due to its potential for abuse and lack of accepted medical use. It is often included in legislation targeting synthetic cannabinoids and other new psychoactive substances.
